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ABSTRACT Novel, double-chained pyridinium com-
pounds have been developed that display highly efficient DNA
transfection properties. The transfection efficiency of several
of these compounds is enhanced by an order of magnitude,
when compared with the transfection efficiency accomplished
with the widely used cationic lipid system, lipofectin. Most
importantly, the pyridinium compounds were found to be
essentially nontoxic toward cells. Using various reporter
genes, such as b-galactosidase and pNEO (a gene construct
that renders cells resistent to antibiotic derivatives of neomy-
cin like G418), we demonstrate that the enhanced efficiency
relates to the fact that a relative higher number of cells in the
population is transfected ('50% in the case of COS cells) by
the pyridinium derivatives, whereas the delivery of DNA per
cell is also enhanced. Furthermore, application of the pyri-
dinium derivatives shows little cellular preference in their
ability to transfect cells. By systematically modifying the
structure of the pyridinium amphiphile, i.e., by changing
either the headgroup structure or the alkyl chains, some
insight was obtained that may lead to unraveling the mecha-
nism of amphiphile-mediated transfection, and thus to pro-
tocols that further optimize the carrier properties of the
amphiphile. Our results reveal that unsaturated alkyl chains
enhance the transfection properties of the pyridinium-based
amphiphiles. Preliminary experiments suggest that the struc-
ture-dependent improvement of transfection efficiency, when
comparing pyridinium derivatives with lipofectin, likely re-
lates to the mechanism of delivery rather than the packaging
of the amphiphileyDNA complex.
Oligonucleotide andyor gene therapy are promising ap-
proaches not only in the treatment of diseases with a genetic
defect (e.g., cystic fibrosis), but also in developing therapeutic
strategies for diseases such as cancer, infectious diseases (e.g.,
AIDS, hepatitis), and acquired diseases (e.g., Parkinson dis-
ease, rheumatic arthritis). For gene therapy to be effective at
least three conditions must be satisfied: (i) a functional gene
must be placed in an appropriate vector, (ii) after internaliza-
tion the gene must be transferred to the nucleus, and (iii) the
gene must integrate in the endogenous genome where it has to
be translated and transcribed. Under certain conditions, i.e.,
when applying for example herpes simplex virus or human
papova BK virus (BKV) viral vectors, episomal replication can
also be envisaged (1). Oligonucleotide-based therapeutic strat-
egies, i.e., antisense or antigene DNA therapy, aimed at
modulating the expression of genes having gone awry, require
analogous needs to be met, including nucleotide stability and
targeting.
So far, no general protocol has been developed for the
efficacious treatment of any particular genetic defect (2, 3).
One of the major problems shared in common by both
approaches involves the delivery per se of the DNA or
oligonucleotide into the cell, both in terms of intracellular
delivery efficiencies and carrier-related toxicity. The methods
used so far rely on either viral systems (reconstituted virus
particles, adenoviruses) (4–6) or chemicophysical technology
(polymers, electroporation, calcium–phosphate precipitation,
and liposomes) (3, 7, 8).
During the last decade, vesicles composed of cationic syn-
thetic amphiphiles have been developed for the delivery of
genes and they have become particularly popular tools in vitro,
as well as in vivo (9–13). Nucleic acids associate with amphi-
philes in a highly efficient manner, and protocols for prepa-
ration and delivery are simple. Moreover, the transfection
efficiencies are usually better than those obtained by proce-
dures, as mentioned above. However, a major drawback in the
application of synthetic amphiphiles has been the severe
cellular toxicity of such compounds.
The mechanism by which these compounds, complexed with
nucleic acids, interact with the cell membrane and thereby
deliver their content into the cell is still not understood. Fusion
(9, 14), endocytosis (15, 16), or a combination of these two (17)
have been proposed as possible mechanisms, but irrefutable
evidence for either of these mechanisms has yet to be pre-
sented. Also, structural requirements related to the ability of
synthetic amphiphiles to transfect cells remain largely obscure.
However, such insight is highly desirable for improving the
transfection efficiency and in efforts to synthesize novel am-
phiphiles of lower toxicity without a loss of potency.
In 1944, pyridinium-derived amphiphiles were described
that displayed some interesting features, such as having anti-
septic and antibiotic properties. It was also noted that these
amphiphiles were essentially nontoxic in vivo (18). More
recently, Sudho¨lter et al. (19) showed that it was possible to
form vesicles from simple fully synthetic pyridinium amphi-
philes. In conjunction with our previous work (20) concerning
the mechanism of amphiphile-mediated transfection, these
findings prompted us to design and prepare several pyri-
dinium-based amphiphiles, depicted in Fig. 1, which were
systematically modified to determine molecular parameters
that govern their transfection ability and their toxicity.
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This work describes the properties of novel amphiphiles,
abbreviated as SAINT (Synthetic Amphiphile INTeraction).
These compounds display superior transfection properties
compared with lipofectin in terms of efficiency and toxicity.
MATERIALS AND METHODS
Synthesis of Amphiphiles. Alkyl halides that could not be
purchased commercially were prepared by reduction of the
corresponding esters or acids. The resulting alcohol was tosy-
lated, followed by bromination or iodination with LiBr or NaI
in acetone: (4-bromobutyl)-trimethylammonium bromide was
synthesized as described (21). The general procedure is out-
lined in Fig. 2.
The various pyridinium-derived amphiphiles (Fig. 1) have
been synthesized according to established procedures (22),
with minor modifications. Briefly, a solution of lithium diiso-
propylamide in dry ether (0.2 M; 2.1 eq) was added to a
solution of freshly distilled 4-methylpyridine (0.1 M) in dry
ether at 2158C. After stirring for 30 min at 2158C, the alkyl
halide (bromide or iodide; 2 eq) was added. The mixture was
stirred overnight at room temperature. Ether was added and
the reaction mixture was washed twice with a 1 M NH4Cl
solution, dried over Na2SO4, and evaporated to dryness. The
product was either crystallized from acetone or purified by
Al2O3 chromatography (neutral, activity II-III), using gradient
elution, starting with hexane followed by hexaneyether (5:1,
volyvol). The resulting alkylpyridines were quaternized with an
excess of CH3I in acetone for 1 h at room temperature to give
product A. Product B was obtained by refluxing a mixture of
the alkylpyridine (1.5 eq) with (4-bromobutyl)-trimethylam-
monium bromide (1 eq) in ethanol for 3 days. The product was
purified by chromatography over Al2O3 (neutral, activity
II-III), starting with chloroform as the eluent to remove the
excess of alkylpyridine. Elution with 10% methanol in chlo-
roform gave the pure compound, which was crystallized from
acetonitrile.
Warming a mixture of alkyl dihalide (1 eq) at 608C for 4 h
with an excess of alkylpyridine (1.1 eq) followed by Al2O3
chromatography (neutral, activity II-III) using gradient elu-
tion, starting with dichloromethane and then 10%methanol in
dichloromethane, yielded the pure compound C.
All bromide or iodide salts were converted into the chlorides
by ion-exchange chromatography using Dowex 1 3 8 200–400
mesh (Cl2 form). Compounds were eluted with CH3OH.
Cell Culture. COS-7 and CV-1 cells were cultured in Costar
flasks in Dulbecco’s modified Eagle’s medium (GIBCO),
containing 7% fetal calf serum (FCS), 2 mM L-glutamine
(GIBCO), 100 units per ml penicillin (GIBCO), and 100
mgyml streptomycin (GIBCO) at 378C in 5% CO2y95% air.
Baby hamster kidney (BHK) cells were cultured in Costar
flasks in Glasgow’s modified Eagle’s medium (GIBCO), con-
taining 7% FCS, 2 mM L-glutamine (GIBCO), 100 units per
ml penicillin (Gist-Brocades), 100 mgyml streptomycin (Bio-
chemie), 7.5% NaHCO3, 12.5% tryptose phosphate broth
(GIBCO), and 2 M Hepes at 378C in 5% CO2y95% air.
Preparation of Vesicles. Chloroform solutions of N-[1-(2,3-
dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride
(DOTMA; synthesized as described in ref. 20) and dioleoyl
phosphatidylethanolamine (1:1) (DOPE, Avanti Polar Lipids),
or the pyridinium amphiphiles (Fig. 1) and DOPE (1:1), were
dried under a stream of nitrogen. The residual solvent was
removed under vacuum. The lipid film was then redissolved in
water and sonicated to clarity in a bath sonicator in a closed
vial. The small unilamellar vesicles thus obtained were steril-
ized by filtration.
Transfection Assay. The cells were transfected by adding a
complex of DNA [pCAT, pb-galactosidase (b-gal), or pNEO;
Promega] and vesicles, prepared by mixing lipid and nucleic
acid at appropriate ratios, as described in the legends.
Throughout this study, 1 mg of DNA was used and the
concentration of amphiphile was varied. Chloramphenicol acetyl-
transferase (CAT) activity was determined as described (20).
b-Gal staining was performed 2 days after transfection.
Cells were washed twice with PBS and fixed with 0.5%
glutardialdehyde (Merck) in PBS. After two more washes with
PBS, the staining solution {0.02% Nonidet P-40y0.01% so-
dium deoxycholatey1 mM MgCl2y5 mM K3[Fe(CN6)]y5 mM
K4[Fe(CN6)]y1 mg/ml 5-bromo-4-chloro-3-indoyl-b-D-
galactopyranoside (stock solution 5 20 mgyml dimethylform-
amide, Boehringer Mannheim)} was added and the cells were
incubated overnight.
One day after transfection, cells transfected with pNEO
were diluted (1:20) and replated. After another 24 h the cells
were put on culture medium supplemented with 400 mgyml
geneticin (G418, Boehringer Mannheim). After 2 weeks, the
number of cells was measured by protein determination (23).
Determination of Cell Toxicity. The toxicity was determined
as the number of cells surviving the transfection experiment by
measuring the protein content. The control value (100% of
FIG. 2. General procedure for the synthesis of pyridinium amphiphiles A, B, and C. (i) Et2O,2158C, LDA, RX. (ii) A: MeI, acetone, rt; B: EtOH,
reflux, Br(CH2)4N1(CH3)3; C: 0.5 eq Br(CH2)nBr, neat 608C.
FIG. 1. Structure of the novel pyridinium compounds.
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surviving cells) was obtained from the amount of cellular
protein remaining after the cells had undergone the transfec-
tion protocol, without the addition of the cationic amphiphiley
DNA complex. Microscopic examination excluded the possi-
bility of dead cells remaining attached to the plates. Only cells
displaying a typical fracture plane of the membrane, which is
indicative of living cells, were seen. To corroborate these
results, the amount of lactate dehydrogenase (LDH) in the
cells after they have been transfected was also measured. The
LDH content was determined using Cytotox 96 228, a nonra-
dioactive cytotoxicity assay (Promega). The 100% value is
obtained from the amount of LDH measured in nontrans-
fected cells.
Hemolysis of Erythrocytes. Erythrocytes were isolated from
whole blood samples. To 40 ml of KPN buffer solution (120
mMKCly10 mMNa2HPO4z2H2Oy30 mMNaCl, pH 7.4) 10 ml
of A1 red blood cells were added. The cells were centrifuged
at 58C (5 min at 3000 rpm) and the pellet was resuspended in
40 ml of KPN buffer. Cells were recentrifuged until the
supernatant was clear. The pellet was then resuspended in 30
ml of KPN buffer.
10E8 erythrocytes were added to the DNAyvesicle complex
in a total volume of 0.6 ml. After various time intervals at 378C,
0.4 ml of Hepes buffered saline was added and the cells were
centrifuged immediately (3 min at maximal speed in an
Eppendorf table centrifuge at 58C). The supernatant was then
screened for the presence of hemoglobin by measuring the
absorbance at 540 nm. To determine the 100% value, the cells
were lysed with Triton X-100 (1% volyvol, final concentration).
DNA Binding Assay. For DNA binding measurements,
complexes of different amounts of vesicles and 1 mg of DNA
were made as described. The complexes were incubated for 10
min at room temperature and then placed on top of a 0.8%
agarose gel in 0.5 3 TBE (100 mM EDTAy56 mM boric
acidy56mMTriszHCl, pH 7.4). The charge ratio was calculated
by measuring the amount of lipid needed to bind all the DNA,
i.e., the amount of lipid at which (free) DNA no longer
migrated into the gel.
RESULTS
Structural Requirements for Efficient Transfection by Pyri-
dinium Amphiphiles. An extensive synthesis protocol was
developed to produce the compounds listed in Fig. 1. Subse-
quently, vesicles consisting of the indicated amphiphile and
DOPE (1:1) were prepared as described. The ability of these
vesicles to mediate transfection, as accomplished by DNA
delivery, was determined by measuring the CAT activity in cell
lysates. The lead for the synthesis of these amphiphiles was
dictated by the initial observation that the pyridinium chloride,
substituted with two C16:0 alkyl chains at the C4 position of the
pyridinium ring structure (SAINT-1), displayed DNA carrier
properties. A transfection efficiency compatible to that of the
widely used lipofectin (9) was obtained. Of further interest was
the observation that SAINT-1 was persistently less toxic than
lipofectin, monitored by protein loss and LDH leakage. Con-
sequently, additional pyridinium analogs were synthesized to
determine the structural parameters relevant for transfection
per se, and to investigate whether derivatives could be obtained
with a higher efficiency and a lower toxicity.
First, an elongation of the alkyl chains to C18:0 (SAINT-5;
Table 1) showed a reduction by a factor of about 2 in the
transfection efficiency relative to that of SAINT-1, but also a
decrease in the toxicity. Interestingly, when substituting one of
the saturated C18:0 alkyl chains for an unsaturated C18:1 alkyl
chain (SAINT-8, C18:0yC18:1), the transfection efficiency in-
creased by an order of magnitude, compared with the disatu-
rated compound (SAINT-5) and 2- to 3-fold compared with
SAINT-1 and lipofectin. Because chain unsaturation drasti-
cally improved the transfection efficiency, the next obvious
goal was be to test the diunsaturated compound. As shown in
Table 1, such a compound (SAINT-2, C18:1yC18:1) was 10–30
times more efficient than the disaturated compound, indicat-
ing that an unsaturation in the hydrocarbon tail leads to an
enhanced transfection efficiency. Most importantly, the im-
proved transfection efficiency (see below) was not paralleled
by a concomitant increase in toxicity.
Upon analyzing SAINT-2 for the configuration of the
double bonds, it was established by double resonance NMR
that 85% was in the cis orientation. To investigate the rele-
vance of a cis versus a trans orientation, unsaturated com-
pounds, consisting of either pure trans or pure cis C18:1yC18:1
derivatives, were prepared. As is apparent from Table 1, the
trans-orientation (SAINT-4) enhances the transfection effi-
ciency compared with the transfection activity of the com-
pound with cis-oriented alkyl chains (SAINT-7).
Apart frommodulating the alkyl chains, it is equally possible
that the headgroup structure (Figure 1C) significantly affects
the transfection efficiency, particularly since the cationic
charge is relevant for interaction with the negatively charged
nucleic acid. This structural parameter was examined using
disaturated C16:0 derivatives for reasons of synthetic conve-
nience. Table 1 shows that an additional cationic charge
improves the transfection efficiency, which is in agreement
with other studies (24). The flanking group of the charged
nitrogen does not seem to dominate the transfection efficiency
(SAINT-3 versus SAINT-9). Rather, the intermolecular dis-
tances between the cationic charges appears to be more
relevant. Thus, with a C4 spacing group (SAINT-9 and
SAINT-3) the highest transfection efficiency is obtained when
compared with SAINT-1. Lower transfection efficiencies are
obtained with shorter (C3) or longer (C5) spacers. However,
compared with the observed enhancement in transfection
efficiencies obtained by modulating the alkyl chains, the
described effects originating from variations in the headgroup
structure are less prominent.
Pyridinium Amphiphiles Are only Slightly Toxic. Although
several types of synthetic amphiphile formulations are efficient
carriers for delivering oligonucleotides and genes into cells,
they have also been noted for their notorious cell toxicity. As
already mentioned above, the pyridinium-derived amphiphiles
appear to display little if any toxic effects toward the cells
examined. As is apparent from the data summarized in Table
Table 1. Transfection activity and toxicity of different amphiphiles










DOTMAyDOPE 36–71 30–40 1
SAINT-1yDOPE 38–77 10–20 1
SAINT-2yDOPE 15–38 0–25 8
SAINT-3yDOPE 8–15 0–20 2.5
SAINT-4yDOPE 15–38 0–30 12
SAINT-5yDOPE 15–38 0–10 0.6
SAINT-7yDOPE 5–38 0–40 10
SAINT-8yDOPE 5–38 0–30 3
SAINT-9yDOPE 38–77 0 4
SAINT-12yDOPE 5 5 1.2
SAINT-13yDOPE 5–10 25–40 2.5
*The concentration given is the concentration range at which the
amphiphile is active.
†The toxicities given here are the toxicities measured at the active
concentration range, i.e., at the highest and lowest concentration
given, respectively.
‡The different transfection efficiencies reflect themaximal efficiencies
found within the amphiphile concentration range given and are
expressed relative to the efficiency obtained with DOTMAyDOPE
(51). Transfection efficiencies were determined in at least three
different experiments. Average values are given. (Error 6 10%.)
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1, pyridinium-derived amphiphiles are only marginally toxic;
often more than 90% of the cells survive the transfection
experiments at the concentration of amphiphile needed for
optimal transfection. Only SAINT-13 showed significant cell
death (25–40%) after the transfection. This value is compa-
rable to that for DOTMAyDOPE induced cell death.
To corroborate these results, the amount of LDH in the cells
after they have been transfected was also measured. Fig. 3
shows the LDH and protein content of cells transfected with
SAINT-2yDOPE or with DOTMAyDOPE vesicles. Note that
the LDH leakage (squares) is more pronounced than the
decrease in protein content (circles) and that LDH loss does
not parallel protein loss. The data suggest that both amphi-
philes effectively permeabilize cells. However, the permeabi-
lization does not necessarily lead to a similar extent of cell
damage leading to cell death, as reflected by the dissimilarity
in amphiphile concentration-dependent protein loss.
Cell Type Dependence. It has been shown that not all cell
types are equally susceptible to transfection with DOTMAy
DOPE vesicles (9, 20). It was therefore of interest to examine
the versatility of the SAINT derivatives in this respect. BHK
cells, which are hardly transfected with DOTMAyDOPE,
displayed a relatively high transfection susceptibility toward
SAINT-2yDOPE (Table 2). Note that compared with lipofec-
tin, the transfectability increased '20-fold. Also, 36C2.21
cells, an immortalized oligodendrocyte cell line, show a more
efficient transfection when SAINT-2yDOPE is used as a
carrier system in comparison with DOTMAyDOPE (Table 2).
It must be noted however that the order of magnitude to which
SAINT-2yDOPE exceeds DOTMAyDOPE is clearly cell type
dependent. Nevertheless, in all cases, a much higher transfec-
tion efficiency was obtained when the transfection was carried
out with SAINT-2yDOPE.
SAINT-2 Mediates Higher Transfection in Terms of Cell
Number and Delivery per Cell. Of major importance is the
question whether the higher efficiency of SAINT-2-mediated
transfection is related to its ability to transfect a higher number
of cells, or whether a higher amount of DNA per cell is
delivered. Two approaches were taken to determine the effi-
ciency of DNA delivery in terms of the number of cells
transfected per population. First, the cells were transfected
with a pNEO gene construct, which renders neomycin resis-
tence toward cells expressing the gene. Second, cells were
transfected with a gene construct expressing b-gal, allowing an
estimation of the number of transfected cells based upon a
blue-staining of cells expressing the gene. As shown in Fig. 4,
when cells have been transfected with pNEO, using DOTMAy
DOPE as a DNA carrier, 23% of the cells have taken up the
DNA, as reflected by an efficient protection of that cell
fraction against antibiotic treatment. However, when the cells
have been transfected using SAINT-2yDOPE as a DNA
carrier, more than 45% of the cell population showed resis-
tence toward the neomycin treatment. Very similar results
were obtained when carrying out analogous experiments, using
b-gal as the reporter gene. Of the cells treated with DOTMAy
DOPE, about 30% were positively (blue) stained, whereas of
the cells treated with SAINT-2yDOPE, this number increased
to around 45% (Table 3). Taken together, a higher number of
cells per population have acquired the gene constructs when
delivered via SAINT-2yDOPE vesicles. The enhancement of
delivery is '1.5-fold when comparing lipofectin with
SAINT-2, whereas in terms of CAT gene expression an
increase of an order of magnitude is frequently seen (Table 1).
Hence, these data also imply that the delivery per cell must be
severalfold higher when using SAINT-2 as the nucleic acid
carrier.
Pore Formation and Transfection Capacity. In previous
work (20) we observed that lipofectin effectively creates pores
in cell membranes, as reflected by the release of hemoglobin
when erythrocytes are incubated with the synthetic amphi-
phile. At relatively high DNAyamphiphile ratios the nucleic
acid reduces amphiphile-induced hemolysis. At lower ratios a
relatively enhanced andyor synergistic DNA effect on amphi-
phile-induced hemolysis is observed. Membrane permeabili-
zation may be related to the mechanism of DNA delivery by
synthetic amphiphiles (20). Di-dodecyl dimethylammonium
bromide is ineffective in bringing about transfection (results
not shown). Neither does the amphiphile trigger hemolysis
(Fig. 5). Analogous to DOTMA (20), SAINT-2 is capable of
triggering hemolysis. Interestingly, in contrast to the synergis-
tic effect of DNA on hemolysis, seen in the case of DOTMA,
such synergism is not immediately apparent for the SAINT-
2yDNA complex, but some synergism may occur given the
similarity in hemolysis of the free amphiphile and the complex.
However, in the lipid concentration range required for optimal
FIG. 3. Amphiphile-induced cell toxicity, monitored by protein loss
and LDH leakage after transfection, as a function of the amphiphile
concentration. Cells were transfected with a complex of 1 mg of DNA
and different amounts of DOTMAyDOPE (open symbols) or with a
complex of 1 mg of DNA and different amounts of SAINT-2yDOPE
(cross-hatched symbols). After the transfection, protein content (cir-
cles) and LDH content (squares) were determined.












COS-7 71 1 15 10
CV-1 71 1 15 10
BHK 71 0.2 45 4
36C2.21 36 2 23 5
Different cell types were transfected with a complex of DOTMAyDOPE and 1 mg of DNA, and with a complex
of SAINT-2yDOPE and 1 mg of DNA. The concentration of amphiphile given is the concentration at which the
amphiphile exhibits the most efficient transfection. Note that the transfection efficiencies given are expressed
relative to that obtained in COS-7 cells, using DOTMAyDOPE (51). Average values are given as determined
in at least three different experiments. (Error 6 10%.)
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transfection efficiency, DOTMA triggers a substantially higher
extent of hemolysis (around 50 mM) than SAINT-2 (around 20
mM). It would appear therefore that there is no direct corre-
lation between the extent of hemolysis and transfection effi-
ciency. However, the remarkable differences in their ability to
trigger hemolysis may reflect differences in the structural
nature of the two complexes. A direct interaction of amphi-
phile and the erythrocyte membrane is necessary for triggering
hemolysis, and the presence of DNA, apart from displaying
synergistic properties on amphiphile-induced hemolysis, can
also sterically interfere, thereby inhibiting amphiphile-induced
hemolysis. These properties are more prominently featured in
the case of lipofectin than with SAINT-2 (Fig. 5). Therefore,
some initial efforts were made to determine potential differ-
ences in DNA-complex formation with either amphiphile.
Some Characteristics of DNA Complexes Formed with
SAINT-2 and DOTMA. To determine the binding efficiency of
DNA to both amphiphiles, complex formation between DNA
and amphiphile was analyzed by agarose gel chromatography,
which allows the determination of the binding ratio of DNAy
amphiphile. The complexes were prepared by mixing different
amounts of SAINT-2yDOPE or DOTMAyDOPE and a fixed
amount of DNA (1 mg). The samples were subsequently
chromatographed on agarose gel, and the charge ratio was
calculated after establishing the conditions at which free DNA
no longer migrates into the gel. In this manner a charge ratio
of 3.65 6 0.05 (n 5 3) was determined for SAINT-2yDOPE,
whereas a ratio of 4.30 6 0.05 (n 5 3) was obtained for
DOTMAyDOPE. Hence, with regard to the amount of DNA
complexed to either SAINT-2 or DOTMA, there appears to be
no major difference between both systems.
Since DOTMA is more potent in triggering membrane
perturbations, as reflected by an enhanced ability to induce
hemolysis, the ‘‘shielding’’ of the amphiphilic molecules by
DNA in the DOTMA complex might differ from that in the
SAINT-2 complex, taking into account that the amphiphile’s
direct accessibility to and interaction with the erythrocyte
membrane is required for membrane perturbation (20). The
‘‘compactness’’ of the SAINT-2 and DOTMA complexes was
therefore examined by determining the extent of DNA deg-
radation after treatment with DNase I at 378C. However, for
both systems, significant degradation was not observed (not
shown), implying that both amphiphiles effectively ‘‘shielded’’
the complexed DNA.
DISCUSSION
In this study, we have described the development of a series of
novel pyridinium-based amphiphiles, which display a highly
efficient ability to transfect cells. This efficiency relates to their
ability (i) to transfect cells that are not easily transfected by
other amphiphiles, such as lipofectin; (ii) to transfect a relative
high number of cells per cell population (approximately in the
order of 50%); and (iii) to deliver a relatively high number of
DNA per cell. Compared with lipofectin, SAINT-2-mediated
DNA delivery per cell is enhanced by about 3- to 6-fold, taking
into account that the transfection efficiency is about an order
of magnitude higher, whereas the relative number of trans-
fected cells was increased by a factor of about 1.5.
Concerning the comparison with other amphiphiles with
respect to improvement of transfection efficiency, it is of
relevance to carry out comparable studies, using the various
amphiphiles in parallel, since the net differences in efficiency
are related to the cell type studied. For example, BHK cells are
difficult to transfect with lipofectin. SAINT-2yDOPE, how-
ever, readily transfects such cells with an efficiency that is
improved by a factor of about 20. The relative meaning of such
a number is emphasized when analyzing the data in Table 2,
showing that transfection with lipofectin of BHK cells ap-
proaches back ground level.
An important feature of these pyridinium-derived amphi-
philes is their relatively low toxicity toward the cells tested,
toxicity being a major drawback in the application of many
amphiphiles thus far. At first sight, the far lower concentra-
tions of the pyridinium amphiphiles needed to induce trans-
FIG. 4. Stable transfection of COS-7 cells. Two weeks after trans-
fection the cells were screened for their protein content, which is a
measure of the number of cells that survived, and thus a measure of
the number of transfected cells. The cells were transfected with a
complex of DNA (pNEO) and the indicated amphiphiles. 1, 36 mM
DOTMAyDOPE (1:1); 2, 15 mM SAINT-2yDOPE (1:1); 3, calcium
phosphate precipitationmethod. The results are expressed as themean
of at least four experiments (6SD). All amphiphiles were significantly
different from DOTMAyDOPE (P , 0.025).
FIG. 5. AmphiphileyDNA membrane interaction induces mem-
brane permeabilization. As a measure of membrane perturbation, the
ability of SAINT-2 and DOTMA to induce hemolysis of erythrocytes
was examined as a function of vesicle and DNA concentration. The
100% value was obtained by treating cells with 1%Triton X-100, which
results in total cell lysis. Cells were treated either with amphiphiles
alone (circles) or amphiphiles complexed to 5 mg of DNA (squares).
Cells were treated with two different amphiphile preparations,
DOTMAyDOPE (open symbols) and SAINT-2yDOPE (cross-
hatched symbols).




stained cells % of total*
DOTMAyDOPE 32.6 6 2.3
SAINT-2yDOPE 45.3 6 1.2
COS-7 cells were incubated with the optimal concentrations of the
indicated amphiphiles complexed to 1mg of DNA (b-gal). After 2 days,
the number of cells with blue staining were counted, representing the
number of cells transfected.
*Amount 6 SD; n 5 4.
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fection (Table 1) may explain this improvement. Yet, the
reduced toxicity appears to be an inherent property of these
derivatives. At concentrations much higher than those re-
quired for transfection, toxicity is still marginal, compared with
the toxicity observed when the cells were treated with lipo-
fectin (Fig. 3). As noted before, the nontoxic properties of
pyridinium salts, as well as their therapeutic properties per se,
were already recognized more than 50 years ago (18). Obvi-
ously, these properties offer an additional attractive rationale
for applying this class of amphiphiles as efficient carriers for
nucleic acids in antisense andyor gene therapy.
A major issue of interest is obviously the underlying mech-
anism as to why SAINT-2 and similar analogs are more
effective in the delivery of DNA to and into cells, than the
compound used for comparison in this work, lipofectin. We
have demonstrated that several structural parameters strongly
affect the transfection efficiency. Alkyl chain ‘‘mobility’’ ap-
pears to be an important parameter in this regard. Thus,
long-saturated alkyl chains reduce the transfection efficiency.
Chain unsaturation may lead to more dynamic packing fea-
tures, in terms of chain orientation in a bilayer. It should be
noted that DOTMA also contains two C18:1 (oleyl) carbon
chains. Preliminary experiments suggest that the complex
formed is not aberrent in terms of DNA packing, since the
nucleic acid packaged with an equal efficiency in both lipo-
fectin and SAINT-2. Neither differed the accessibility to
DNase in either system. These considerations suggest the
relevance of structural features of the amphiphile in the actual
delivery process of the DNA. This would also be in line with
observations that the nonbilayer lipid DOPE frequently facil-
itates the entry of DNA into cells when employing amphi-
philes. It is possible that the unsaturated alkyl chains facilitate
a permeabilization of the cellular membranes, a feature typical
for amphiphiles that are capable of causing cellular transfec-
tion. As noted above, the cationic di-dodecyl dimethylammo-
nium bromide is incapable of transferring DNA into cells.
Consistently, the amphiphile does not permeabilize red blood
cells. Whether this inability relates to an effect of the chain
length, since the longer chain analog dioctadecyl dimethylam-
monium bromide appears to have good transfection efficien-
cies (25), remains to be determined.
Our previous observations (20) suggested that permeabili-
zation may be an important step in the translocation of DNA
across membranes. This work reveals that although both types
of amphiphiles (SAINT-2 and DOTMA) permeabilize cellular
membranes (Figs. 3 and 5), there appears to exist no propor-
tional relationship between membrane perturbation and trans-
fection efficiency. In fact, the process is more subtle, which also
becomes apparent when comparing the release of LDH (Fig.
3) with amphiphile-induced perturbation of erythrocyte mem-
branes (Fig. 5). At the optimal concentration at which
SAINT-2 brings about transfection ('15 mM) LDH release is
still marginal, whereas hemoglobin release numbers '10–
15%.
In the case of lipofectin (optimum ' 50 mM), LDH release
is '50%, whereas hemoglobin release has occurred to the
same extent. This could indicate that the latter extent of
permeabilization is not a priori required to obtain efficient
delivery. Hence, the effects of DOTMA likely reflect a major
toxic effect toward the cells, whereas SAINT-2 may reflect a
more selective permeabilization allowing DNA translocation.
Apart from a role of the alkyl chains in the processes as
described above, it is also likely that the headgroup, containing
the cationic charge necessary for interaction with the nucleic
acid, is of considerable significance. Upon delivery, the DNA
has to ‘‘dissociate’’ from the amphiphile (26). It is evident that
the nature of the headgroupmaymodulate such a property and
thereby affect transfection efficiency. In fact, while keeping the
alkyl chain constant, subtle structural changes in the head-
group structure can change the transfection efficiency up to
severalfold (Table 1).
Further work will be needed to more carefully define the
various structural parameters involved. The current amphiphi-
lic system should allow us to obtain such mechanistic insight.
Nevertheless, this work has shown that the novel pyridinium-
related amphiphiles have great potency in applications involv-
ing nucleotide therapies, both with respect to their efficiency
and in terms of marginal toxicity.
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